VYGR — Voyager Therapeutics, Inc.

—
Nasdaq · Health Care · Biotechnology · CIK 1640266 ·
Last close
$1.52
Market Cap
$94.59M
52W High
$5.48
52W Low
$1.50
ADV30
1,004,482
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 4,014,000 — -26,422,000 -24,694,000 177,053,000 48,408,000 41,942,000
Jun 2026 3,165,000 — -26,392,000 -24,473,000 197,753,000 35,769,000 43,376,000
Mar 2026 2,593,000 — -30,270,000 -27,937,000 219,325,000 43,314,000 45,656,000
Dec 2025 15,336,000 — -29,932,000 -27,426,000 252,281,000 65,300,000 56,200,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-120,572,000
Investing CF
$105,804,000
Financing CF
$6,459,000
CapEx
$-1,952,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.81
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-498,315,000
Inventory
—
Receivables
$3,154,000
ST Investments
$80,569,000
EBIT TTM
$-117,188,000
Pretax Income TTM
$-107,602,000
Interest Exp TTM
—
Analysts
9

Yahoo Snapshot (yfinance, live)

Total Revenue
$25,108,000
EBITDA
$-105,791,000
Free Cash Flow
$-64,756,500
Enterprise Value
$39,758,424
Total Cash
$106,806,000
Total Debt
$30,507,000
Shares Out
62,229,182
Trailing EPS
$-1.74
Book Value
$2.17
ROE
-58.9%
ROA
-29.4%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 40,374,000 -131,844,000 -119,721,000 252,281,000 56,200,000 196,081,000 -132,467,000
Dec 2024 80,001,000 -83,287,000 -65,002,000 393,050,000 93,290,000 299,760,000 -15,310,000
Dec 2023 250,008,000 122,014,000 132,330,000 351,281,000 114,961,000 236,320,000 77,919,000
Dec 2022 40,907,000 -50,837,000 -46,408,000 159,356,000 100,336,000 59,020,000 -12,509,000

TTM Snapshot

Revenues TTM
$34,459,000
NetIncome TTM
$-107,728,000
OpCashFlow TTM
—
Assets (Latest)
$197,753,000
Forward EPS
$-1.28

Max Pain — expiry 2027-04-16 (volume-derived — Yahoo OI feed degraded)

max pain strike: $3.00 · spot: $1.67 · call volume: 169 · put volume: 341
Expected Move to 2027-04-16: ±$1.47 (88.02%) — implied range $0.20 – $3.14 · ATM straddle on $2.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
ARMP Armata Pharmaceuticals, Inc. $98.93M $2.66 —
ZURA Zura Bio Ltd $99.70M $1.03 —
OTLK Outlook Therapeutics, Inc. $87.79M $0.36 —
VXRT Vaxart, Inc. $86.51M $0.35 —
BDTX Black Diamond Therapeutics, Inc. $82.75M $1.44 —

News headlines (Yahoo Finance, 1h cache)

Voyager Therapeutics Eyes Tau Antibody Data and Alzheimer’s Gene Therapy Dosing
2026-11-16 06:12 · Yahoo
Voyager Therapeutics (VYGR) Reports Q3 Loss, Lags Revenue Estimates
2026-11-05 21:45 · Yahoo
Voyager Therapeutics: Q3 Earnings Snapshot
2026-11-05 21:34 · Yahoo
Voyager Reports Third Quarter 2026 Financial and Operating Results
2026-11-05 21:01 · Yahoo
Voyager’s Tau-Targeted Gene Therapy VY1706 and Anti-Tau Antibody VY7523 for Alzheimer’s Disease to Be Featured in Poster Presentations at CTAD 2026
2026-10-27 12:01 · Yahoo
Voyager Announces CEO Succession Plan, Appoints Robin Swartz President
2026-10-21 12:01 · Yahoo
Voyager to Present at Upcoming Investor Conferences
2026-09-01 12:00 · Yahoo
Voyager Therapeutics (VYGR) Reports Q2 Loss, Misses Revenue Estimates
2026-08-06 23:10 · Yahoo
Voyager Demonstrates Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 6-Month GLP Toxicology Study; Initiation of Clinical Trial in Alzheimer’s Disease Expected H2 2026
2026-07-13 12:01 · Yahoo
Cramer to a 23-Year-Old: Buy It, but It Might Take a ‘Lifetime’ to Make Money
2026-07-02 13:33 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.